Coldstream Capital Management Inc. Acquires Shares of 1,918 The Cooper Companies, Inc. (NASDAQ:COO)

Coldstream Capital Management Inc. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,918 shares of the medical device company’s stock, valued at approximately $208,000.

Several other hedge funds and other institutional investors also recently modified their holdings of COO. Innealta Capital LLC bought a new position in Cooper Companies during the second quarter worth $25,000. Ashton Thomas Securities LLC acquired a new stake in shares of Cooper Companies during the third quarter worth $25,000. Crewe Advisors LLC raised its holdings in shares of Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the period. Tortoise Investment Management LLC lifted its position in shares of Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after buying an additional 169 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the period. Institutional investors own 24.39% of the company’s stock.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.00% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $94.49 on Wednesday. The firm has a market capitalization of $18.86 billion, a PE ratio of 48.46, a P/E/G ratio of 2.52 and a beta of 0.97. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $103.04 and a 200 day moving average price of $99.00. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period last year, the firm posted $0.87 earnings per share. The business’s revenue was up 9.8% on a year-over-year basis. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on COO shares. Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, Robert W. Baird boosted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.